• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于卵巢储备标志物预测 IVF/ICSI 周期中 FSH 起始剂量的公式。

A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF/ICSI cycles.

机构信息

Reproductive Medicine Center, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Zhongshan North Road 53, Nanjing, 210008, Jiangsu, People's Republic of China.

Reproductive Medical Center of Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing, 210002, Jiangsu, People's Republic of China.

出版信息

Arch Gynecol Obstet. 2019 Aug;300(2):441-446. doi: 10.1007/s00404-019-05156-2. Epub 2019 Apr 11.

DOI:10.1007/s00404-019-05156-2
PMID:30976971
Abstract

BACKGROUND

Although exogenous follicle-stimulating hormone (FSH) has been used for decades and millions of cycles have been performed worldwide until now, criteria for selecting the proper FSH starting dose have not been clearly identified. The aim of this study was to elaborate a formula based on markers of ovarian reserve for the calculation of the appropriate starting dose of FSH.

METHODS

A total of 931 patients underwent in vitro fertilization (IVF) treatment using long GnRH agonist protocol was retrospectively identified and reviewed. 673 cases of them with a normal ovarian response (4-14 retrieved oocytes) were used to analysis the predictive formula. All follicles 4-7 mm in diameter were counted in the same day of blood sample in both ovaries using transvaginal ultrasound scan. The modified protocol of each patient was recorded and analyzed in the same center. In another center were the numbers of retrieved oocytes of 750 validated patients recorded and analyzed.

RESULTS

A formula model based on age, AMH, and antral follicle count (AFC) was able to accurately predict the ovarian sensitivity and accounted for 57.2% of the variability of ovarian response to FSH. When tested in the same total population used to elaborate the model it predicts a high 46.88% rate of step-down protocol in higher-starting FSH dose group and about 57.92% of patients had their dose step-up modified in lower-starting FSH dose group during their treatment, respectively. And when tested in different population from another center used to elaborate the model it predicts a high 64.40% rate of ≥ 15 retrieved oocytes in higher-starting FSH dose group and about 22.50% of patients had ≤ 7 retrieved oocytes in lower-starting FSH dose group during their treatment, respectively.

CONCLUSIONS

In the present study we demonstrated that the individualized FSH starting dose may be calculated on the basis of a woman's age, AMH and AFC. The formula model might be a useful, immediate, and easily applicable tool for clinicians to predict the tailored starting dose of FSH during their daily clinical practice.

摘要

背景

虽然外源性促卵泡激素(FSH)已经使用了几十年,并且到目前为止已经在全球范围内进行了数百万个周期,但选择合适的 FSH 起始剂量的标准尚未明确确定。本研究的目的是制定一个基于卵巢储备标志物的公式,用于计算 FSH 的适当起始剂量。

方法

回顾性确定并分析了 931 名接受长 GnRH 激动剂方案体外受精(IVF)治疗的患者。其中 673 例卵巢反应正常(4-14 个获卵),用于分析预测公式。使用经阴道超声扫描在同一天计数双侧卵巢中 4-7mm 的所有卵泡。记录并分析每位患者的改良方案,均在同一中心进行。在另一个中心记录并分析了 750 名经验证患者的获卵数。

结果

基于年龄、AMH 和窦卵泡计数(AFC)的公式模型能够准确预测卵巢敏感性,占 FSH 卵巢反应变异性的 57.2%。在用于构建模型的相同总体人群中进行测试时,它预测在较高起始 FSH 剂量组中,下调方案的比例高达 46.88%,约 57.92%的患者在治疗期间修改了较低起始 FSH 剂量组的剂量上调。在用于构建模型的不同人群中进行测试时,它预测在较高起始 FSH 剂量组中,获得≥15 个获卵的比例高达 64.40%,在较低起始 FSH 剂量组中,获得≤7 个获卵的比例约为 22.50%。

结论

在本研究中,我们证明可以根据女性的年龄、AMH 和 AFC 计算个体化的 FSH 起始剂量。该公式模型可能是临床医生在日常临床实践中预测 FSH 起始剂量的有用、即时且易于应用的工具。

相似文献

1
A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF/ICSI cycles.基于卵巢储备标志物预测 IVF/ICSI 周期中 FSH 起始剂量的公式。
Arch Gynecol Obstet. 2019 Aug;300(2):441-446. doi: 10.1007/s00404-019-05156-2. Epub 2019 Apr 11.
2
Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study.个体化起始促卵泡激素剂量在 GnRH 拮抗剂方案 IVF/ICSI 中治疗多囊卵巢综合征患者中的剂量列线图:一项回顾性队列研究。
Adv Ther. 2023 Sep;40(9):3971-3985. doi: 10.1007/s12325-023-02582-2. Epub 2023 Jul 3.
3
Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.抗苗勒管激素、促卵泡生成素及窦卵泡计数对接受 GnRH 拮抗剂方案进行体外受精/胚胎移植的女性卵巢刺激结局的预测价值。
Arch Gynecol Obstet. 2014 Dec;290(6):1249-53. doi: 10.1007/s00404-014-3332-3. Epub 2014 Jul 8.
4
[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].国产高纯度尿促卵泡素对控制性卵巢刺激中体外受精-胚胎移植结局的影响
Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42.
5
Nomogram to predict FSH starting dose in poor ovarian response women in progestin primed ovarian stimulation protocol.预测孕激素预处理卵巢刺激方案中卵巢反应不良患者 FSH 起始剂量的列线图。
BMC Womens Health. 2023 Apr 28;23(1):202. doi: 10.1186/s12905-023-02327-x.
6
Does the anti-Müllerian hormone truly reflect ovarian response in women with endometrioma?抗苗勒管激素真的能反映患有子宫内膜异位囊肿女性的卵巢反应吗?
J Obstet Gynaecol. 2019 May;39(4):516-521. doi: 10.1080/01443615.2018.1533542. Epub 2019 Feb 11.
7
Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles.基于卵巢储备标志物的列线图用于个体化体外受精周期中促卵泡生成素起始剂量。
BJOG. 2012 Sep;119(10):1171-9. doi: 10.1111/j.1471-0528.2012.03412.x. Epub 2012 Jul 17.
8
Effect of different starting doses of FSH on laboratory and clinical outcomes in patients with moderate AMH level.不同起始剂量 FSH 对 AMH 水平中等的患者实验室及临床结局的影响。
Hormones (Athens). 2024 Jun;23(2):331-338. doi: 10.1007/s42000-024-00527-0. Epub 2024 Feb 12.
9
Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.根据窦卵泡计数对体外受精/卵胞浆内单精子注射周期中的促卵泡激素起始剂量进行个体化处理。
J Ovarian Res. 2013 Feb 6;6(1):11. doi: 10.1186/1757-2215-6-11.
10
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.基于年龄、血清卵泡刺激素(FSH)和抗缪勒管激素(AMH)的列线图在体外受精/卵胞浆内单精子注射(IVF/ICSI)周期中选择FSH起始剂量的临床应用:一项回顾性双中心研究
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:94-99. doi: 10.1016/j.ejogrb.2016.10.021. Epub 2016 Oct 26.

引用本文的文献

1
A retrospective study: establishment and validation of the prediction model for the gonadotropin starting dose in IVF/ICSI-ET among normal ovarian response women.一项回顾性研究:正常卵巢反应女性体外受精/卵胞浆内单精子注射-胚胎移植中促性腺激素起始剂量预测模型的建立与验证
Front Endocrinol (Lausanne). 2025 Jun 23;16:1600936. doi: 10.3389/fendo.2025.1600936. eCollection 2025.
2
Oocyte Cryopreservation in Women with Ovarian Endometriosis.卵巢子宫内膜异位症女性的卵母细胞冷冻保存
J Clin Med. 2023 Oct 26;12(21):6767. doi: 10.3390/jcm12216767.
3
Effectiveness and Safety of Recombinant Human Follicle-Stimulating Hormone (Follitrope™) in Inducing Controlled Ovarian Stimulation in Infertile Women in Real-World Practice: a Prospective Cohort Study.
在真实世界实践中,重组人卵泡刺激素(Follitrope™)在诱导不孕女性控制性卵巢刺激中的有效性和安全性:一项前瞻性队列研究。
Reprod Sci. 2023 Sep;30(9):2842-2852. doi: 10.1007/s43032-023-01228-6. Epub 2023 Apr 17.
4
Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation.促性腺激素起始剂量预测模型及其在控制性卵巢刺激中的临床应用。
BMC Pregnancy Childbirth. 2022 Nov 4;22(1):810. doi: 10.1186/s12884-022-05152-6.
5
Novel nomogram-based integrated gonadotropin therapy individualization in in vitro fertilization/intracytoplasmic sperm injection: A modeling approach.基于新型列线图的体外受精/卵胞浆内单精子注射促性腺激素治疗个体化:一种建模方法
Clin Exp Reprod Med. 2021 Jun;48(2):163-173. doi: 10.5653/cerm.2020.03909. Epub 2021 May 12.